Skip to content
Disclosery

TAKEDA PHARMACEUTICAL CO LTD

Follow

13F filer, CIK 1395064, Tokyo, Japan

TAKEDA PHARMACEUTICAL CO LTD reported $19,553,783 across 11 holdings for the quarter ended 2025-06-30, in a 13F-HR filed 2025-08-08. Its ten largest share positions make up 99.9% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001395064-25-000124

Period
2025-06-30
Reported value
$19.6M
Holdings
11
Top 10 weight
99.9%
New
0
Sold out
0

Largest buys vs the previous quarter

None.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
LYELL IMMUNOPHARMA INCreduced-782,152-$6.91M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q2 2025

Share positions as resolved from 13F-HR 0001395064-25-000124, largest first. % of portfolio is the value over $19,553,783, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
HILLEVAX INCHILLEVAX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: 6,724,000 shares; 2024Q1: 6,724,000 shares; 2024Q2: 6,724,000 shares; 2024Q3: 6,724,000 shares; 2024Q4: 6,724,000 shares; 2025Q1: 6,724,000 shares; 2025Q2: 6,724,000 shares 6,724,000$13.4M68.43%0
OVIDOVID THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: 7,531,996 shares; 2024Q1: 7,531,996 shares; 2024Q2: 7,531,996 shares; 2024Q3: 7,531,996 shares; 2024Q4: 7,531,996 shares; 2025Q1: 7,531,996 shares; 2025Q2: 7,531,996 shares 7,531,996$2.49M12.71%0Timeline
XLOXilio Therapeutics Inc.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: 1,475,121 shares; 2024Q1: 1,475,121 shares; 2024Q2: 1,475,121 shares; 2024Q3: 1,475,121 shares; 2024Q4: 1,475,121 shares; 2025Q1: 1,475,121 shares; 2025Q2: 1,475,121 shares 1,475,121$1M5.13%0Timeline
AMWLAMERICAN WELL CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: 1,554,669 shares; 2024Q1: 1,554,669 shares; 2024Q2: 1,554,669 shares; 2024Q3: 77,733 shares; 2024Q4: 77,733 shares; 2025Q1: 77,733 shares; 2025Q2: 77,733 shares 77,733$691K3.53%0Timeline
EQEQUILLIUM INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: 1,824,977 shares; 2024Q1: 1,824,977 shares; 2024Q2: 1,824,977 shares; 2024Q3: 1,824,977 shares; 2024Q4: 1,824,977 shares; 2025Q1: 1,824,977 shares; 2025Q2: 1,824,977 shares 1,824,977$575K2.94%0Timeline
STTKSHATTUCK LABS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: 2,090,858 shares; 2024Q1: 1,501,061 shares; 2024Q2: 515,619 shares; 2024Q3: 515,619 shares; 2024Q4: 515,619 shares; 2025Q1: 515,619 shares; 2025Q2: 515,619 shares 515,619$408K2.09%0Timeline
LYELL IMMUNOPHARMA INCLYELL IMMUNOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: not reported; 2024Q1: not reported; 2024Q2: not reported; 2024Q3: not reported; 2024Q4: 823,317 shares; 2025Q1: 823,317 shares; 2025Q2: 41,165 shares 41,165$364K1.86%-782,152
TURNSTONE BIOLOGICS CORPTURNSTONE BIOLOGICS CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: 895,824 shares; 2024Q1: 895,824 shares; 2024Q2: 895,824 shares; 2024Q3: 895,824 shares; 2024Q4: 895,824 shares; 2025Q1: 895,824 shares; 2025Q2: 895,824 shares 895,824$322K1.64%0
THRDTHIRD HARMONIC BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: not reported; 2024Q1: not reported; 2024Q2: not reported; 2024Q3: not reported; 2024Q4: 36,835 shares; 2025Q1: 36,835 shares; 2025Q2: 36,835 shares 36,835$200K1.02%0Timeline
RANIRANI THERAPEUTICS HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: 338,679 shares; 2024Q1: 338,679 shares; 2024Q2: 215,172 shares; 2024Q3: 203,190 shares; 2024Q4: 203,190 shares; 2025Q1: 203,190 shares; 2025Q2: 203,190 shares 203,190$104K0.53%0Timeline
LABSTANDARD BIOTOOLS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: 16,515 shares; 2024Q1: 16,515 shares; 2024Q2: 16,515 shares; 2024Q3: 16,515 shares; 2024Q4: 16,515 shares; 2025Q1: 16,515 shares; 2025Q2: 16,515 shares 16,515$19.8K0.1%0Timeline

How Q2 2025 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001395064-25-000124 base2025-08-08acceptance time not in the bulk data set